Medivir AB Release: Lipsovir(R) Has Entered Phase III Clinical Study

STOCKHOLM, Sweden--(BUSINESS WIRE)--July 6, 2006--Lipsovir® (ME-609) is Medivir's labial herpes project. The aim of the phase III study is to show that early initiation of treatment with Lipsovir® will prevent the development of labial herpes (cold sores).